Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer

Clinical trial NCT07315854 · RECRUITING

Trial details

NCT number: NCT07315854
Sponsor: Beijing Friendship Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer (GC)Gastroesophageal Junction Cancer Advanced Gastric Cancer Metastatic Gastric Cancer

Start date: 2025-11-04
Primary completion: 2027-12-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.